# S-amlodipine+Chlorthalidone vs S-amlodipine+Telmisartan in Hypertension

> **NCT03226340** · PHASE4 · UNKNOWN · sponsor: **Seoul National University Bundang Hospital** · enrollment: 170 (estimated)

## Conditions studied

- Essential Hypertension

## Interventions

- **DRUG:** S-amlodipine 2.5mg + Chlorthalidone 25mg
- **DRUG:** S-amlodipine 2.5mg + Telmisartan 40mg

## Key facts

- **NCT ID:** NCT03226340
- **Lead sponsor:** Seoul National University Bundang Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-12-02
- **Primary completion:** 2018-03-31
- **Final completion:** 2018-03-31
- **Target enrollment:** 170 (ESTIMATED)
- **Last updated:** 2017-07-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03226340

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03226340, "S-amlodipine+Chlorthalidone vs S-amlodipine+Telmisartan in Hypertension". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03226340. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*